Perceptions in Type 1 Diabetes Mellitus with or Without the Use of Insulin Pump: An Online Study

Author(s): Emmanouil S. Benioudakis*

Journal Name: Current Diabetes Reviews

Volume 16 , Issue 8 , 2020


Become EABM
Become Reviewer
Call for Editor

Abstract:

Background: Technological developments concerning the treatment of Type 1 Diabetes Mellitus have been rapid in the latest years. Insulin infusion systems along with continuous glucose monitoring, as well as long-acting insulin analogues, are part of this progress.

Objective: The aim of this study is to present the illness perceptions in type 1 diabetes mellitus, with or without the use of an insulin pump. Sexual life and body image among therapy groups subjected to subcutaneous insulin infusion (CSII) therapy and multiple daily injections (MDI) therapy were also examined.

Methods: A modified version of the Brief Illness Perception Questionnaire was used. One hundred and nine adults with type 1 diabetes mellitus, (males / females ratio 1:2.3) completed the online survey. Thirty six of them (33%) used CSII therapy and 73 of them (67%) used MDI therapy.

Results: Statistically important differences among the CSII and MDI therapy groups were found in treatment control, illness comprehensibility, representations of control, representation of body image and in the perception of sex life. There was no statistically significant difference among the different types of therapy for participants’ negative perception of diabetes.

Discussion and Conclusion: Negative perceptions of MDI users in treatment control, illness comprehensibility, representations of control, body image and sex life with the insulin pump, differentiate CSII and MDI therapy groups to a significant degree. According to the research, these parameters seem to interfere with accepting CSII therapy for MDI users and discourage them.

Keywords: Type 1 diabetes mellitus, brief illness perception questionnaire, sex life, continuous subcutaneous insulin infusion, multiple daily injections, online study.

[1]
Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017; 128: 40-50.
[http://dx.doi.org/10.1016/j.diabres.2017.03.024] [PMID: 28437734]
[2]
Kekäläinen P, Tirkkonen H, Laatikainen T. How are metabolic control targets of patients with Type 1 diabetes mellitus achieved in daily practice in the area with high diabetes prevalence? Diabetes Res Clin Pract 2016; 115: 9-16.
[http://dx.doi.org/10.1016/j.diabres.2016.03.005] [PMID: 27242117]
[3]
Peters JC, Hindmarsh CP, Thompson JR. Insulin pump thera-py. Paediatr Child Health 2017; 27: 160-5.
[http://dx.doi.org/10.1016/j.paed.2017.02.002]
[4]
Marom L. Insulin pump access issues for visually impaired people with type 1 diabetes. Diabetes Res Clin Pract 2010; 89(1): e13-5.
[http://dx.doi.org/10.1016/j.diabres.2010.04.005] [PMID: 20444517]
[5]
Wu YP, Graves MM, Roberts MC, Mitchell AC. Is insulin pump therapy better than injection for adolescents with diabetes? Diabetes Res Clin Pract 2010; 89(2): 121-5.
[http://dx.doi.org/10.1016/j.diabres.2010.04.010] [PMID: 20488572]
[6]
Duke DC, Barry S, Wagner DV, Speight J, Choudhary P, Harris MA. Distal technologies and type 1 diabetes management. Lancet Diabetes Endocrinol 2018; 6(2): 143-56.
[http://dx.doi.org/10.1016/S2213-8587(17)30260-7] [PMID: 28867311]
[7]
Cesur M, Cesur A. Double diabetes: possible but unpublished complication of insulin pump therapy. J Diabetes Complications 2008; 22(2): 147-9.
[http://dx.doi.org/10.1016/j.jdiacomp.2006.10.002] [PMID: 18280447]
[8]
Didangelos T, Iliadis F. Insulin pump therapy in adults. Diabetes Res Clin Pract 2011; 93(Suppl. 1): S109-13.
[http://dx.doi.org/10.1016/S0168-8227(11)70025-0] [PMID: 21864741]
[9]
Ruiz-de-Adana MS, Dominguez-Lopez ME, Gonzalez-Molero I, et al. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study. Med Clin (Barc) 2016; 146(6): 239-46.
[http://dx.doi.org/10.1016/j.medcli.2015.09.020] [PMID: 26656958]
[10]
Krzymien J, Rachuta M, Kozlowska I, Ladyzynski P, Foltyn-ski P. Treatment of patients with type 1 diabetes – Insulin pumps or multiple injections? Biocybern Biomed Eng 2016; 36: 1-8.
[http://dx.doi.org/10.1016/j.bbe.2015.10.002]
[11]
Renard E. Insulin pump use in Europe. Diabetes Technol Ther 2010; 12(Suppl. 1): S29-32.
[http://dx.doi.org/10.1089/dia.2009.0189] [PMID: 20515303]
[12]
Purewal R, Fisher PL. The contribution of illness perceptions and metacognitive beliefs to anxiety and depression in adults with diabetes. Diabetes Res Clin Pract 2018; 136: 16-22.
[http://dx.doi.org/10.1016/j.diabres.2017.11.029] [PMID: 29203257]
[13]
Hudson JL, Bundy C, Coventry PA, Dickens C. Exploring the relationship between cognitive illness representations and poor emotional health and their combined association with diabetes self care. A systematic review with meta-analysis. J Psychosom Res 2014; 76(4): 265-74.
[http://dx.doi.org/10.1016/j.jpsychores.2014.02.004] [PMID: 24630175]
[14]
Wolf FM, Jacober SJ, Wolf LL, Cornell RG, Floyd JC Jr. Quality of life activities associated with adherence to insulin infusion pump therapy in the treatment of insulin dependent diabetes mellitus. J Clin Epidemiol 1989; 42(12): 1129-36.
[http://dx.doi.org/10.1016/0895-4356(89)90110-8] [PMID: 2585004]
[15]
Seereiner S, Neeser K, Weber C, et al. Attitudes towards insulin pump therapy among adolescents and young people. Diabetes Technol Ther 2010; 12(1): 89-94.
[http://dx.doi.org/10.1089/dia.2009.0080] [PMID: 20082590]
[16]
Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res 2006; 60(6): 631-7.
[http://dx.doi.org/10.1016/j.jpsychores.2005.10.020] [PMID: 16731240]
[17]
Ng TS. Brief illness perception questionnaire (Brief IPQ). J Physiother 2012; 58(3): 202.
[http://dx.doi.org/10.1016/S1836-9553(12)70116-9] [PMID: 22884192]
[18]
Riveline JP, Franc S, Biedzinski M, et al. Groupe Pompe Sud-Francilien. Sexual activity in diabetic patients treated by continuous subcutaneous insulin infusion therapy. Diabetes Metab 2010; 36(3): 229-33.
[http://dx.doi.org/10.1016/j.diabet.2010.01.004] [PMID: 20303814]
[19]
Waite M, Martin C, Franklin R, Duce D, Harrison R. Human factors and data logging processes with the use of advanced technology for adults with type 1 diabetes: Systematic integra-tive review. JMIR Human Factors 2018; 5(1) e11
[http://dx.doi.org/10.2196/humanfactors.9049] [PMID: 29535079]
[20]
Low KG, Massa L, Lehman D, Olshan JS. Insulin pump use in young adolescents with type 1 diabetes: a descriptive study. Pediatr Diabetes 2005; 6(1): 22-31.
[http://dx.doi.org/10.1111/j.1399-543X.2005.00089.x] [PMID: 15787898]
[21]
Ziegler R, Cavan DA, Cranston I, et al. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial. Diabetes Care 2013; 36(11): 3613-9.
[http://dx.doi.org/10.2337/dc13-0251] [PMID: 23900590]
[22]
Peyrot M, Skovlund SE, Landgraf R. Epidemiology and correlates of weight worry in the multinational Diabetes Attitudes, Wishes and Needs study. Curr Med Res Opin 2009; 25(8): 1985-93.
[http://dx.doi.org/10.1185/03007990903073654] [PMID: 19555311]
[23]
Beato-Víbora P, Chico-Ballesteros A, Giménez M, et al. Diabetes Technology Working Group of the Spanish Diabetes Association. A national survey on the efficacy and safety of continuous subcutaneous insulin infusion in patients with type 1 diabetes in Spain. Diabetes Res Clin Pract 2018; 137: 56-63.
[http://dx.doi.org/10.1016/j.diabres.2017.12.009] [PMID: 29278712]
[24]
Lepore G, Bonfanti R, Bozzetto L, et al. Italian Study Group on the Diffusion of CSII. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion. Nutr Metab Cardiovasc Dis 2018; 28(4): 335-42.
[http://dx.doi.org/10.1016/j.numecd.2017.12.001] [PMID: 29428572]
[25]
Jakisch BI, Wagner VM, Heidtmann B, et al. German/Austrian DPV Initiative and Working Group for Paediatric Pump Therapy. Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years. Diabet Med 2008; 25(1): 80-5.
[http://dx.doi.org/10.1111/j.1464-5491.2007.02311.x] [PMID: 18199134]
[26]
Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004; 27(7): 1554-8.
[http://dx.doi.org/10.2337/diacare.27.7.1554] [PMID: 15220227]
[27]
Cherie SYG, Amir M, Yung SL, et al. The associations of self-care, illness perceptions and psychological distress with metabolic control in Singaporean adolescents with type 1 dia-betes mellitus. Health Psychol Behav Med 2016; 4: 1-14.
[http://dx.doi.org/10.1080/21642850.2015.1115728]
[28]
Kramer G, Kuniss N, Kloos C, et al. Principles and frequency of self-adjustment of insulin dose in people with diabetes mellitus type 1 and correlation with markers of metabolic control. Diabetes Res Clin Pract 2016; 116: 299-305.
[http://dx.doi.org/10.1016/j.diabres.2016.04.025] [PMID: 27321348]
[29]
Alonso Martín DE, Roldán Martín MB, Álvarez Gómez MÁ, et al. Impact of diabetes education on type 1 diabetes mellitus control in children. Endocrinol Nutr 2016; 63(10): 536-42.
[http://dx.doi.org/10.1016/j.endonu.2016.08.004] [PMID: 27765490]
[30]
Selam LJ. CSII in Europe: where are we, where are we going? An analysis of articles published in infusystems international. Diabetes Res Clin Pract 2006; 74: S123-6.
[http://dx.doi.org/10.1016/S0168-8227(06)70014-6]
[31]
Hanaire H, Lassmann-Vague V, Jeandidier N, et al. Treatment of diabetes mellitus using an external insulin pump: the state of the art. Diabetes Metab 2008; 34(4 Pt 2): 401-23.
[http://dx.doi.org/10.1016/S1262-3636(08)73972-7] [PMID: 18951116]
[32]
Saha S, Riemenschneider H, Müller G, Levin-Zamir D, Van den Broucke S, Schwarz PEH. Comparative analysis of diabetes self-management education programs in the European Union Member States. Prim Care Diabetes 2017; 11(6): 529-37.
[http://dx.doi.org/10.1016/j.pcd.2017.05.011] [PMID: 28663021]
[33]
Harvey JN, Lawson VL. The importance of health belief models in determining self-care behaviour in diabetes. Diabet Med 2009; 26(1): 5-13.
[http://dx.doi.org/10.1111/j.1464-5491.2008.02628.x] [PMID: 19125754]
[34]
Maiorino MI, Bellastella G, Castaldo F, Petrizzo M, Giugliano D, Esposito K. Sexual function in young women with type 1 diabetes: the METRO study. J Endocrinol Invest 2017; 40(2): 169-77.
[http://dx.doi.org/10.1007/s40618-016-0542-5] [PMID: 27613610]
[35]
Kichler JC, Foster C, Opipari-Arrigan L. The relationship between negative communication and body image dissatisfaction in adolescent females with Type 1 Diabetes Mellitus. J Health Psychol 2008; 13(3): 336-47.
[http://dx.doi.org/10.1177/1359105307088138] [PMID: 18420768]
[36]
Lenhard JM. A new look at patient selection criteria for con-tinuous subcutaneous insulin infusion (CSII). Diabetes Res Clin Pract 2006; 74: S140.
[http://dx.doi.org/10.1016/S0168-8227(06)70018-3]
[37]
Shiyanbola OO, Unni E, Huang YM, Lanier C. The association of health literacy with illness perceptions, medication beliefs, and medication adherence among individuals with type 2 diabetes. Res Social Adm Pharm 2018; 14(9): 824-30.
[http://dx.doi.org/10.1016/j.sapharm.2017.12.005] [PMID: 29317189]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 8
Year: 2020
Page: [874 - 880]
Pages: 7
DOI: 10.2174/1573399815666190502115754
Price: $65

Article Metrics

PDF: 19
HTML: 1